Cardiovascular Effects of Empagliflozine
NCT02918591
·
clinicaltrials.gov ↗
NA
Phase
UNKNOWN
Status
10
Enrollment
OTHER
Sponsor class
Conditions
Type 2 Diabetes
Interventions
DRUG:
Empagliflozine
Sponsor
Tel Aviv University